Payment Initiation definition

Payment Initiation means an online service to initiate a payment order at the request of the Service” payment service user with respect to a payment account held at another payment service provider “Payment Initiation is a payment service provider who supplies a Payment Initiation Service Service Provider” or (“PISP”)
Sample 1
Payment Initiation. ) means a Payment Order to execute a single Outgoing Credit Transfer, submitted to the Bank via another payment service provider. It may only be presented to the Bank for execution in relation to the Payment Account to which the Bank provides the Client with the Direct Banking Services, namely Internet Banking. With regard to its authorization or execution, some
Sample 1
Payment Initiation means a payment order initiated at the request of an End User from their Source Account to your Account; Payment Initiation Service or PIS – means a service to initiate a payment from a Source Account, as more particularly described in clause 3. Source Account – a payment account accessible online which an End User holds with an ASPSP;
Sample 1

Examples of Payment Initiation in a sentence

  • Nuapay shall operate as a Payment Initiation Service Provider (PISP).

  • Payment Initiation Services – an online service which accesses your Monese Account to initiate the transfer of funds on your behalf.

  • Authorised Third Party Provider – Includes Account Information Service Provider and/or Payment Initiation Service Provider.

  • Scheduled Payment Initiation Dates must be prior to any late date or the end of any grace period.

  • Any prompt payment discount will be calculated from the Payment Initiation Date referred to above.

  • Sofort – a Payment Initiation Service Provider whose service may allow you to authorise SEPA Credit Transfers and/or bank transfers to the Monese App from bank accounts in various countries.

  • You are responsible for any late charge, finance charge, penalty or default or other consequence that may result from your selecting a Payment Initiation Date later than the due date.

  • If the actual due date falls on a non-Business Day, you must select a Payment Initiation Date that is at least one (1) Business Day before the actual due date.

  • Payments will be credited to your Loan on the scheduled Payment Initiation Date after 3:45 pm ET.

  • Payment Initiation Services - represents the initiation services for Payment Instructions upon the Client's request regarding a Current Bank Account accessible online, except for Credit accounts whereby the Client can only perform operations related to the Credit granted by BCR.


More Definitions of Payment Initiation

Payment Initiation. ) means a Payment Order to execute a single Outgoing Credit Transfer, submitted to the Bank via another payment service provider. It may only be presented to the Bank for execution in relation to the Payment Account to which the Bank provides the Client with the Direct Banking Services, namely Internet Banking. With regard to its authorization or execution, some limitations (such as spending limits) and time limits for the execution of Payment Transactions, such as for Payment Orders submitted via Internet Banking, apply. A User who is entitled to place and authorize the same types of Payment Orders via Internet Banking is entitled to make and authorize Indirectly Given Payment Orders.
Sample 1
Payment Initiation means the preparation of a payment order by gathering information and filling them out in paper or digital form before its receipt and execution by the payer's account-holding payment service provider. A payment initiation can be carried out by the payer's account-holding payment service provider in the case of credit transfer, by the payee's account- holding payment service provider in the case of direct debit, or by a third party payment service provider in either case;
Sample 1
Payment Initiation. “Service Provider”
Sample 1

Related to Payment Initiation

  • payment initiation service means a service to initiate a payment order at the request of the payment service user with respect to a payment account held at another payment service provider;

  • Initiation fee means a fee charged by us to you in order to create a credit facility for you;

  • Payment Initiation Service Provider or “PISP” means an authorised third party provider which provides a service that allows that third party to pass payment instructions to us on your behalf in relation to your Account.

  • Initiation means, with respect to a Clinical Trial, the administration of the first dose to a patient in such Clinical Trial.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • clinical evidence means clinical data and clinical evaluation results pertaining to a device of a sufficient amount and quality to allow a qualified assessment of whether the device is safe and achieves the intended clinical benefit(s), when used as intended by the manufacturer;

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Commercial use request means a re- quest from or on behalf of one who seeks information for a use or purpose that furthers the commercial, trade, or profit interests of the requester or the person on whose behalf the request is made.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Medical Reimbursement Programs means a collective reference to the Medicare, Medicaid and TRICARE programs and any other health care program operated by or financed in whole or in part by any foreign or domestic federal, state or local government.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Medical event means an event that meets the criteria in 12VAC5-481-2080.

  • Processing Fees means all routine, generally applicable City-wide fees required by the City for processing applications and permits including, but not limited to, fees for land use applications, building applications, building permits, and certificates of occupancy.

  • Medical evaluation means the process of assessing an individual's health status that includes a medical history and a physical examination of an individual conducted by a licensed medical practitioner operating within the scope of his license.

  • Phase III Trial means a human Clinical Trial of the Licensed Product, which trial is designed (a) to establish that the Licensed Product is safe and efficacious for its intended use; (b) to define warnings, precautions and adverse reactions that are associated with the Licensed Product in the dosage range to be prescribed; and (c) consistent with 21 CFR § 312.21(c).

  • Medical Child Support Order means any judgment, decree or order (including approval of a domestic relations settlement agreement) issued by a court of competent jurisdiction that:

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Medical support means providing health care coverage for a joint child by carrying health care coverage for the joint child or by contributing to the cost of health care coverage, public coverage, unreimbursed medical expenses, and uninsured medical expenses of the joint child.